 Zacks Investment Research upgraded shares of Establishment Labs NASDAQ:ESTA from a hold rating to a buy rating in a research note published on Monday morning, Zacks.com reports. They currently have 13.00 price objective on the stock. According to Zacks, Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and ... 